RadBio E24: Radiosensitizers & Bioreductive Drugs

Описание: In our previous discussions, we've established that factors like tumor hypoxia can significantly limit the effectiveness of radiation therapy. Today, we're diving into strategies designed to overcome this and other forms of radioresistance. We'll explore agents that make tumor cells more vulnerable to radiation – the radiosensitizers. Specifically, we'll look at halogenated pyrimidines that get incorporated into DNA, and the electron-affinic nitroimidazoles that target hypoxic cells by mimicking oxygen. We’ll also touch upon how these nitroimidazoles can be used for imaging tumor hypoxia. Then, we'll shift to another class of agents, bioreductive drugs or hypoxic cytotoxins, like Tirapazamine, which are cleverly designed to become toxic specifically in the low-oxygen environment of tumors. Understanding these modifiers is key to appreciating ongoing efforts to enhance the therapeutic ratio in radiation oncology.